Raymond James & Associates’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-13,250
| Closed | -$4.75K | – | 4025 |
|
|
2024
Q2 | $4.75K | Sell |
13,250
-700
| -5% | -$251 | ﹤0.01% | 3898 |
|
|
2024
Q1 | $9.35K | Buy |
+13,950
| New | +$9.35K | ﹤0.01% | 3857 |
|
|
2021
Q4 | – | Sell |
-14,585
| Closed | -$131K | – | 4067 |
|
|
2021
Q3 | $131K | Sell |
14,585
-90,650
| -86% | -$814K | ﹤0.01% | 3745 |
|
|
2021
Q2 | $1.26M | Buy |
105,235
+10,115
| +11% | +$121K | ﹤0.01% | 2430 |
|
|
2021
Q1 | $1.19M | Buy |
95,120
+17,100
| +22% | +$214K | ﹤0.01% | 2382 |
|
|
2020
Q4 | $1.22M | Buy |
+78,020
| New | +$1.22M | ﹤0.01% | 2202 |
|
|
2018
Q2 | – | Sell |
-13,627
| Closed | -$259K | – | 3519 |
|
|
2018
Q1 | $259K | Buy |
+13,627
| New | +$259K | ﹤0.01% | 2971 |
|